Rubraca Approved as Maintenance Treatment for Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 30
- Publication type:
- Article
Works matching IS 21644403 AND DT 2018 AND VI 8 AND IP 5
Results: 17
1
2
Adcetris Approved as Initial Treatment for Stage III or IV Classical Hodgkin Lymphoma.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 25
- Publication type:
- Article
3
Verzenio Receives New Indication as Initial Treatment for Metastatic Breast Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 23
- Publication type:
- Article
4
Immunotherapy plus Targeted Therapy Combination Active in Metastatic CRC.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 22
- By:
- Publication type:
- Article
5
Low Survival in Patients with Head and Neck Cancers Linked to Delays in Radiation Therapy After Surgery.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 29
- By:
- Publication type:
- Article
6
Tagrisso Now Approved as First-Line Therapy for Patients with Metastatic NSCLC and EGFR Mutations.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 30
- Publication type:
- Article
7
Cabozantinib Active as First-Line Treatment of Differentiated Thyroid Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 28
- By:
- Publication type:
- Article
8
Nivolumab Shows Durable Activity in Subgroups of Patients with Metastatic CRC.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 20
- By:
- Publication type:
- Article
9
Blincyto Approved for Patients with B-Cell ALL and Minimal Residual Disease.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 27
- Publication type:
- Article
10
Survivorship Guidelines Present Challenges in Primary Care.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 26
- By:
- Publication type:
- Article
11
Managing Immune Checkpoint Inhibitor Side Effects: Key Recommendations.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 17
- By:
- Publication type:
- Article
12
Updated NCCN Prostate Cancer Guideline Emphasizes Risk Stratification.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 14
- By:
- Publication type:
- Article
13
Maintaining Work and Productivity a Priority for Cancer Survivors.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 24
- By:
- Publication type:
- Article
14
What Will It Take for Oncology Practices to Survive?
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 1
- By:
- Publication type:
- Article
15
Using Cancer Drugs Wisely to Control Costs: Targeted Therapies May Hold the Key.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
16
Cancer Vaccine plus Trastuzumab Shows Promise in HER2 Breast Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 1
- By:
- Publication type:
- Article
17
NCCN Issues First Guideline for Immunotherapy-Related Adverse Events.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 5, p. 1
- By:
- Publication type:
- Article